Posted 9/18/2023, 9:23:00 PM

Moderna Stock Drops Over 9% Despite Little News; Co-Founder Sells $1.65 Million in Shares

Moderna stock dropped 9.1% on Monday despite little fundamental news on the company.
Co-founder and board member Noubar Afeyan sold 15,000 shares worth $1.65 million.
The sale was scheduled under SEC Rule 10b5-1, allowing executives to plan sales to reduce positions.
Pfizer and BioNTech shares also declined, suggesting weakness in vaccine stocks overall.
Moderna gained 8.3% last week, so today's drop may just be typical volatility for the stock.

barrons.com

Relevant topic timeline:

8/21/2023

Moderna Surges On A Second, Unexpected Shot At The Cancer Vaccine Market

Moderna's stock surged after the biotech company partnered with Carsgen to study a new cancer vaccine regimen using mRNA technology, giving Moderna a second opportunity in the field of cancer vaccines.

8/24/2023

Dow Falls 300 Points as Early Gains Turn to Nasty Selloff

The stock market experienced a sharp decline as early gains turned into a selloff, with the Dow Jones Industrial Average, S&P 500, and Nasdaq Composite all falling; concerns over rising bond yields and inflation contributed to the sell-off.

8/31/2023

“September Effect”: Are Stock Markets Doomed to Fall? - TipRanks.com

Stocks have historically performed poorly in September, with an average loss of 1.12%, but investors should not base their decisions solely on this statistical trend and should focus on buying fundamentally strong companies at reasonable prices.

9/18/2023

Moderna Stock Drops as COVID Booster Demand Dwindles; Company Pivots to Oncology and Rare Diseases

Moderna's market cap took a hit after Pfizer's announcement that only 24% of eligible Americans will receive a COVID-19 booster shot, but analysts still project a positive outlook for the next five years with the company's expansion into other areas such as oncology and rare diseases. The target price for Moderna stock is $166.25 per share, indicating a potential upside of 59.67%.

9/21/2023

Nvidia Stock Slides in September, Losing $176B Despite Standout Year

Nvidia, the semiconductor giant, has experienced a 10% decline in their stock this month, leading to a $180 billion decrease in market capitalization, attributed to the "September effect," although it remains the best performer in the S&P 500 due to the rise of AI and ChatGPT.